Issue 1/2024
Content (10 Articles)
SGLT2 Inhibitors for Heart Failure with Preserved Ejection Fraction: What Hospitalists Need to Know
Stephen J. Greene, Gregg C. Fonarow, Javed Butler
Cardioprotective Strategies After Ischemia–Reperfusion Injury
Honghong Zhang, Huilin Hu, Changlin Zhai, Lele Jing, Hongen Tian
Iron Dyshomeostasis and Mitochondrial Function in the Failing Heart: A Review of the Literature
Seyed Ali Mousavi-Aghdas, Ebrahim Farashi, Nasim Naderi
A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension
Omnia Azmy Nabeh, Alaa I. Saud, Basma Amin, Amira Samy Khedr, Alaa Amr, Aml Medhat Faoosa, Eshraka Esmat, Yasmeen Magdy Mahmoud, Aya Hatem, Mariam Mohamed, Alaa Osama, Youssef Mohamed Amin Soliman, Reem Ibrahim Elkorashy, Soha Aly Elmorsy
The Use of Sodium-Glucose Cotransporter-2 Inhibitors in Coronary Revascularization: Where Are We Now? A Systematic Review
Ryaan EL-Andari, Nicholas M. Fialka, Jimmy Kang, Sabin J. Bozso, Jayan Nagendran, Jeevan Nagendran
Safety and Efficacy of Cangrelor in Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis
Mostafa Reda Mostafa, Mohamed Magdi Eid, Ahmed K. Awad, Andrew Takla, Abdul Rhman Hassan, Basant E. Katamesh, Majd M. AlBarakat, Abdul Rhman Ziada, Sarah Mohamed, Karim M. Al-Azizi, Andrew M. Goldsweig
Safety and Efficacy of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors After Acute Coronary Syndrome: A Meta-analysis of Randomized Controlled Trials
Ahmed Atia, Heba Aboeldahab, Ahmed Wageeh, Mohamed Elneny, Mohamed Elmallahy, Bashaer Elawfi, Menna M. Aboelkhier, Amr Elrosasy, Maya Magdy Abdelwahab, Somaya Sayed, Ahmed Abdelaziz
Intravenous Diltiazem Versus Metoprolol in Acute Rate Control of Atrial Fibrillation/Flutter and Rapid Ventricular Response: A Meta-Analysis of Randomized and Observational Studies
Alexander Bolton, Bishow Paudel, Mehul Adhaduk, Mohammed Alsuhaibani, Riley Samuelson, Marin L. Schweizer, Denice Hodgson-Zingman
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective
Andre Lamy, John Eikelboom, Wesley Tong, Fei Yuan, Shrikant I. Bangdiwala, Jackie Bosch, Stuart Connolly, Eva Lonn, Gilles R. Dagenais, Kelley R. H. Branch, Wei-Jhih Wang, Deepak L. Bhatt, Jeffrey Probstfield, Georg Ertl, Stefan Störk, P. Gabriel Steg, Victor Aboyans, Isabelle Durand-Zaleski, Lars Ryden, Salim Yusuf
Rivaroxaban Plasma Concentration and Clinical Outcomes on Older Patients with Non-valvular Atrial Fibrillation and Pulmonary Infection
Yan Yu, Haobin Li, Jing Liu, Qing Liang, Juan Xie, Guangchun Sun